APA (7th ed.) Citation

Merz, P., Röckel, N., Ballikaya, S., Auffarth, G. U., & Schmack, I. (2019). Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells. BioMed Central. https://doi.org/https://doi.org/10.1186/s12886-018-0978-9

Chicago Style (17th ed.) Citation

Merz, Patrick, Nina Röckel, Seda Ballikaya, Gerd U. Auffarth, and Ingo Schmack. Effects of Ranibizumab (Lucentis®) and Bevacizumab (Avastin®) on Human Corneal Endothelial Cells. London: BioMed Central, 2019. https://doi.org/https://doi.org/10.1186/s12886-018-0978-9.

MLA (9th ed.) Citation

Merz, Patrick, et al. Effects of Ranibizumab (Lucentis®) and Bevacizumab (Avastin®) on Human Corneal Endothelial Cells. BioMed Central, 2019. https://doi.org/https://doi.org/10.1186/s12886-018-0978-9.